These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7813389)

  • 21. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial.
    Doody RS; Ferris SH; Salloway S; Sun Y; Goldman R; Watkins WE; Xu Y; Murthy AK
    Neurology; 2009 May; 72(18):1555-61. PubMed ID: 19176895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Placebo-controlled double-blind randomized trial on the use of L-carnitine, L-acetylcarnitine, or combined L-carnitine and L-acetylcarnitine in men with idiopathic asthenozoospermia.
    Balercia G; Regoli F; Armeni T; Koverech A; Mantero F; Boscaro M
    Fertil Steril; 2005 Sep; 84(3):662-71. PubMed ID: 16169400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.
    Freund-Levi Y; Eriksdotter-Jönhagen M; Cederholm T; Basun H; Faxén-Irving G; Garlind A; Vedin I; Vessby B; Wahlund LO; Palmblad J
    Arch Neurol; 2006 Oct; 63(10):1402-8. PubMed ID: 17030655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Open-label study of mirtazapine orally disintegrating tablets in depressed patients in the nursing home.
    Roose SP; Nelson JC; Salzman C; Hollander SB; Rodrigues H;
    Curr Med Res Opin; 2003; 19(8):737-46. PubMed ID: 14687445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acetyl-L-carnitine in the treatment of mildly demented elderly patients.
    Passeri M; Cucinotta D; Bonati PA; Iannuccelli M; Parnetti L; Senin U
    Int J Clin Pharmacol Res; 1990; 10(1-2):75-9. PubMed ID: 2201659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
    Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anosognosia in Alzheimer's disease: association with patient characteristics, psychiatric symptoms and cognitive deficits.
    Kashiwa Y; Kitabayashi Y; Narumoto J; Nakamura K; Ueda H; Fukui K
    Psychiatry Clin Neurosci; 2005 Dec; 59(6):697-704. PubMed ID: 16401246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The need for a consensus in the use of assessment tools for Alzheimer's disease: the Feasibility Study (assessment tools for dementia in Alzheimer Centres across Europe), a European Alzheimer's Disease Consortium's (EADC) survey.
    Paulino Ramirez Diaz S; Gil Gregório P; Manuel Ribera Casado J; Reynish E; Jean Ousset P; Vellas B; Salmon E
    Int J Geriatr Psychiatry; 2005 Aug; 20(8):744-8. PubMed ID: 16035121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathological brain ageing: evaluation of the efficacy of a pharmacological aid.
    Guarnaschelli C; Fugazza G; Pistarini C
    Drugs Exp Clin Res; 1988; 14(11):715-8. PubMed ID: 3246216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quetiapine treatment for behavioural and psychological symptoms of dementia in Alzheimer's disease patients: a 6-week, double-blind, placebo-controlled study.
    Paleacu D; Barak Y; Mirecky I; Mazeh D
    Int J Geriatr Psychiatry; 2008 Apr; 23(4):393-400. PubMed ID: 17879256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dose-finding study.
    Naukkarinen H; Raassina R; Penttinen J; Ahokas A; Jokinen R; Koponen H; Lepola U; Kanerva H; Lehtonen L; Pohjalainen T; Partanen A; Mäki-Ikola O; Rouru J;
    Eur Neuropsychopharmacol; 2005 Dec; 15(6):617-23. PubMed ID: 15949921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Depression as prognostic factor: 6 months follow-up in a geriatric institution.
    Shim YS; Yang DW
    Arch Gerontol Geriatr; 2006; 43(2):277-83. PubMed ID: 16427148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening of mild cognitive impairment in Chinese older adults--a multistage validation of the Chinese abbreviated mild cognitive impairment test.
    Lam LC; Tam CW; Lui VW; Chan WC; Chan SS; Chiu HF; Leung T; Tham MK; Ho KS; Chan WM
    Neuroepidemiology; 2008; 30(1):6-12. PubMed ID: 18204291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the effects of L-acetylcarnitine on senile patients suffering from depression.
    Garzya G; Corallo D; Fiore A; Lecciso G; Petrelli G; Zotti C
    Drugs Exp Clin Res; 1990; 16(2):101-6. PubMed ID: 2205455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. L-acetylcarnitine in depressed elderly subjects. A cross-over study vs placebo.
    Tempesta E; Casella L; Pirrongelli C; Janiri L; Calvani M; Ancona L
    Drugs Exp Clin Res; 1987; 13(7):417-23. PubMed ID: 3308388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and neuropsychological study with oxiracetam versus placebo in patients with mild to moderate dementia.
    Villardita C; Parini J; Grioli S; Quattropani M; Lomeo C; Scapagnini U
    J Neural Transm Suppl; 1987; 24():293-8. PubMed ID: 3479527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Evaluation of the efficacy of L-acetylcarnitine and tiapride combination in elderly patients with behavioral disorders].
    De Marco F; Ascione C; Di Pietro E; Ulisse T; D'Ambra L; Carbone M
    Minerva Psichiatr; 1991; 32(2):103-7. PubMed ID: 1870410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.